Matches in Wikidata for { <http://www.wikidata.org/entity/Q90821162> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- Q90821162 description "article scientifique publié en 2018" @default.
- Q90821162 description "artículu científicu espublizáu en setiembre de 2018" @default.
- Q90821162 description "scientific article published on 14 September 2018" @default.
- Q90821162 description "wetenschappelijk artikel" @default.
- Q90821162 description "наукова стаття, опублікована у вересні 2018" @default.
- Q90821162 name "Bendamustine with rituximab, etoposide and carboplatin (T(R)EC) in relapsed or refractory aggressive lymphoma: a prospective multicentre phase 1/2 clinical trial" @default.
- Q90821162 name "Bendamustine with rituximab, etoposide and carboplatin (T(R)EC) in relapsed or refractory aggressive lymphoma: a prospective multicentre phase 1/2 clinical trial" @default.
- Q90821162 type Item @default.
- Q90821162 label "Bendamustine with rituximab, etoposide and carboplatin (T(R)EC) in relapsed or refractory aggressive lymphoma: a prospective multicentre phase 1/2 clinical trial" @default.
- Q90821162 label "Bendamustine with rituximab, etoposide and carboplatin (T(R)EC) in relapsed or refractory aggressive lymphoma: a prospective multicentre phase 1/2 clinical trial" @default.
- Q90821162 prefLabel "Bendamustine with rituximab, etoposide and carboplatin (T(R)EC) in relapsed or refractory aggressive lymphoma: a prospective multicentre phase 1/2 clinical trial" @default.
- Q90821162 prefLabel "Bendamustine with rituximab, etoposide and carboplatin (T(R)EC) in relapsed or refractory aggressive lymphoma: a prospective multicentre phase 1/2 clinical trial" @default.
- Q90821162 P1433 Q90821162-8B282564-BCA7-4C88-B1D0-6FD60A13FAB7 @default.
- Q90821162 P1476 Q90821162-6986C962-1D02-465F-8AA9-1F18379795B4 @default.
- Q90821162 P2093 Q90821162-4D17CB0E-CD43-4DF8-B481-4E76127E7AC2 @default.
- Q90821162 P2093 Q90821162-4FA996EF-7D8D-4CF2-B982-4362111EBE03 @default.
- Q90821162 P2093 Q90821162-84470829-F2B2-401D-9DE3-D349804ADBEC @default.
- Q90821162 P2093 Q90821162-9DB1C223-2069-4C7B-96B5-303ACC3BE2D3 @default.
- Q90821162 P2093 Q90821162-AA958C80-988E-4A3E-BFC1-55624E68366C @default.
- Q90821162 P2093 Q90821162-B401D64B-AF98-4693-9841-B408D78FD033 @default.
- Q90821162 P2093 Q90821162-BF728C8C-50E5-4B41-9982-63BB762AA316 @default.
- Q90821162 P2093 Q90821162-C7483809-732E-4E0A-95EE-2639BBFCDFC9 @default.
- Q90821162 P2093 Q90821162-C8870353-F9F3-4DE5-ABD0-AD9B039EE2FE @default.
- Q90821162 P2093 Q90821162-D36DFBAD-7388-4F18-94B6-DEF7A29A4179 @default.
- Q90821162 P2093 Q90821162-D4B915F0-7277-403D-97AE-0A31A5F272C2 @default.
- Q90821162 P2093 Q90821162-E9CD1550-C9E3-4F9F-BDFE-5B30CB489A22 @default.
- Q90821162 P2093 Q90821162-F658A713-DFA7-4F0D-BD86-12446902AD12 @default.
- Q90821162 P304 Q90821162-24736D1F-70B0-4F52-ABAF-74A79FA5D45C @default.
- Q90821162 P31 Q90821162-A7E5CBED-875D-4534-BCFC-8BF35639D298 @default.
- Q90821162 P356 Q90821162-F9E78312-3ABF-440D-B9B3-E8213F540B87 @default.
- Q90821162 P433 Q90821162-3918CCD4-3A93-4CAC-B2B3-4EBCC669B080 @default.
- Q90821162 P478 Q90821162-C2D25A1C-F5E4-4CAF-A03B-E89D43E33141 @default.
- Q90821162 P50 Q90821162-18D630AB-F2FC-4F6A-9603-3BE7A8136B45 @default.
- Q90821162 P50 Q90821162-38C74679-E9F3-4905-A129-610801877EE8 @default.
- Q90821162 P577 Q90821162-D3C839D4-316E-44D9-84FF-D4294CFE2615 @default.
- Q90821162 P698 Q90821162-D27D180C-87F5-4E96-A33A-C5ACE989E5EE @default.
- Q90821162 P921 Q90821162-16434C59-4E4D-4599-9C67-42609E8E1195 @default.
- Q90821162 P921 Q90821162-2DA53C5B-9786-4E04-9F80-E06DF8546012 @default.
- Q90821162 P921 Q90821162-3AC25326-8DA7-4222-9C30-2378A687A307 @default.
- Q90821162 P921 Q90821162-57FA5D8B-2077-4DEB-B77F-CF178C894A8C @default.
- Q90821162 P921 Q90821162-61F7AEDA-D93E-40E5-B108-C309592497E1 @default.
- Q90821162 P921 Q90821162-98B3EACD-5A1A-4A89-BB19-7ED187B301E1 @default.
- Q90821162 P932 Q90821162-DFC0604F-21D4-4D8B-9A8B-B0DC5F641B87 @default.
- Q90821162 P356 BJH.15585 @default.
- Q90821162 P698 30596402 @default.
- Q90821162 P1433 Q4970200 @default.
- Q90821162 P1476 "Bendamustine with rituximab, etoposide and carboplatin (T(R)EC) in relapsed or refractory aggressive lymphoma: a prospective multicentre phase 1/2 clinical trial" @default.
- Q90821162 P2093 "Alan Langerak" @default.
- Q90821162 P2093 "Andrei R Shustov" @default.
- Q90821162 P2093 "Daniel B Martin" @default.
- Q90821162 P2093 "David Wu" @default.
- Q90821162 P2093 "Edward N Libby" @default.
- Q90821162 P2093 "Eric Y Chen" @default.
- Q90821162 P2093 "Jennifer E Roden" @default.
- Q90821162 P2093 "Kiarash Kojouri" @default.
- Q90821162 P2093 "Mary Philip" @default.
- Q90821162 P2093 "Oliver W Press" @default.
- Q90821162 P2093 "Stephen D Smith" @default.
- Q90821162 P2093 "Tara L Chen" @default.
- Q90821162 P2093 "Ted A Gooley" @default.
- Q90821162 P304 "601-607" @default.
- Q90821162 P31 Q13442814 @default.
- Q90821162 P356 "10.1111/BJH.15585" @default.
- Q90821162 P433 "4" @default.
- Q90821162 P478 "183" @default.
- Q90821162 P50 Q50211582 @default.
- Q90821162 P50 Q90821157 @default.
- Q90821162 P577 "2018-09-14T00:00:00Z" @default.
- Q90821162 P698 "30596402" @default.
- Q90821162 P921 Q412323 @default.
- Q90821162 P921 Q415588 @default.
- Q90821162 P921 Q418817 @default.
- Q90821162 P921 Q425745 @default.
- Q90821162 P921 Q5452194 @default.
- Q90821162 P921 Q6934595 @default.
- Q90821162 P932 "6314205" @default.